VivoSeq
Other

Tracheal Intubation

0

Pipeline Programs

7

Active Trials

1

Companies Involved

Tracheal Intubation is an early-stage landscape with 0 programs across 1 company. The most active players are Avera Pharmaceuticals.

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

96/100

Attrition Rate

3/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

35

clinical trials

Completed23 · 66%
Not yet recruiting4 · 11%
Unknown status4 · 11%
Recruiting2 · 6%
Terminated1 · 3%
Active, not recruiting1 · 3%

Trial Activity

35 trials

Opioid-based Versus Opioid-free Endotracheal Intubation
Completed··N/A·NCT06464393·70 enrolled
Premedication for Non-Emergency Endotracheal Intubation In the NICU
Completed··Phase 4·NCT01749501·45 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)